Showing results (351-360 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 1, 2009
Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenograftsTaras G Balandin, Evelina Edelweiss, Natalia V Andronova, et al.
Investigational New Drugs|October 1, 2009
Antimetastatic activity of MONCPT in preclinical melanoma mice modelXiao-Chun Yang, Chong-Xing Tu, Pei-Hua Luo, et al.
Investigational New Drugs|October 2, 2009
PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosisPiotr Jasinski, Pawel Zwolak, Kaoru Terai, et al.
Investigational New Drugs|May 17, 2011
Antiangiogenic treatments and mechanisms of action in renal cell carcinomaSylvie Négrier, Eric Raymond
Investigational New Drugs|April 29, 2011
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancerDaniel J Renouf, Patricia A Tang, Pierre Major, et al.
Investigational New Drugs|January 21, 2011
Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution studySoohyeon Lee, Sang Hyun Yoon, Jun Yong Park, et al.
Investigational New Drugs|June 10, 2011
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networksYu Kataoka, Toru Mukohara, Hideo Tomioka, et al.
Investigational New Drugs|May 1, 1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancerD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Investigational New Drugs|May 1, 1990
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B reportQ S Ringenberg, K J Propert, H B Muss, et al.
Investigational New Drugs|December 21, 2010
Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21Yongci Zhang, Ming Yang, Qing Ji, et al.
Pageof 372